Company intelligence / Profile preview

Lanchi Ventures

Shanghai, China

Ownership: Private
Development stage: Other

Overview

Lanchi Ventures is a venture capital firm managing over $2 billion in capital. Formerly BlueRun Ventures China, it invests in early- and growth-stage companies across technology sectors including AI, Robotics, Biotech, Consumer, and Digital Health, with a strong focus on Asia and global markets. Notable investments include Li Auto, WaterDrop, and Allink Biotherapeutics.

Industry: Investors

Beyond the preview

Go deeper on Lanchi Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lanchi Ventures.

Explore the full profile